Objectives: Refractory venous ulcers are a national health issue, despite advances in wound care and compression therapy. We examined the impact of compression, correction of incompetent superficial and perforator veins, and dilatation of iliac stenosis/occlusion.
Methods: All patients with venous ulcers from eight institutions, treated between January 2013 and January 2016, were retrospectively evaluated for the impact of different treatment modalities.
Results: A total of 406 patients with venous ulcers, accompanied by reflux in lower extremity deep veins (30%), superficial veins (92%), perforator veins (80%), and with iliac venous stenosis (4%) were treated, and 105 patients (26%) were managed conservatively with compression, for a mean of 3.8 months until ulcer healing. The remaining 301 patients (74%) underwent wound care for a mean of 9 months prior to surgical treatment. There were 276 patients (68%) who underwent ablation of an incompetent great saphenous vein 6.4 months after ulcer onset, 83 patients (20%) underwent ablation of an incompetent small saphenous vein after 11 months, and 288 patients (71%) underwent ablation of an incompetent perforator vein after 21 months. Patients undergoing perforator ablation had a mean of 1.7 perforator veins closed. Ulcer size at beginning of conservative treatment was smaller in those that healed with compression and wound care alone (7 vs 22 cm 2 , respectively; P < .05). Patients with concomitant deep venous reflux required more vein ablations (3.1 vs 1.4 veins, respectively; P < .05) to achieve ulcer healing. Time from onset to ulcer healing for patients requiring only superficial vein ablation was 9.1 months but was 13.8 months for patients requiring both superficial and perforator vein ablation (P < .05). Patients with deep vein incompetence took the longest time to heal, with a mean of 21 months. Stenosis >75% in the femoral or popliteal vein was a significant barrier to ulcer healing (P < .05). In patients with prior superficial vein ablation and iliac vein stenosis >50%, ulcer healing was achieved following iliac vein stenting in 76%. Absolute ulcer healing was achieved during the study period in 336 patients (83%). There were 35 ulcer recurrences (10%) during the study; new incompetent perforator veins were identified in 13 patients (37%).
Conclusions: Patients with multilevel venous disease involving the deep system are at highest risk for developing venous ulcers that are refractory to compression therapy alone. Venous ulcer healing time and rate is improved with ablation of incompetent superficial and perforator veins. Correction of iliac venous stenosis/occlusion also facilitates ulcer healing.
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PC184. Delayed Conversion to Kissing Stent Configuration in the Setting of Unilateral Iliac Vein Stenting
Chien Yi M. Png, Jacob Lurie, Sida Chen, Sneha Subramaniam, Rami O. Tadros, Peter Faries, Michael Marin, Windsor Ting. Icahn School of Medicine at Mount Sinai, New York, NY Objectives: Iliac vein stents are being increasingly used to treat chronic proximal venous outflow obstruction. Among patients with unilateral stenting in the proximal common iliac vein with extension into the inferior vena cava (IVC), a small number of patients presented with venous symptoms related to outflow obstruction of the contralateral common iliac vein. While the incidence of this complication of iliac vein stenting is unknown, this abstract presents one technical approach to this complication.
Methods: We present 11 patients with outflow obstructive symptoms in the contralateral iliac vein after a prior IVC common iliac vein stent placement. Postanesthesia, ultrasound guidance is used to obtain access to the common femoral vein bilaterally. Inferior vena cavograms and venograms of the iliac veins are undertaken using contrast in digital subtraction mode. Intravascular ultrasound (IVUS) using a Volcano Visions PV .035 Digital IVUS catheter (Volcano Corporation, San Diego, Calif) is then used to evaluate the iliac veins and assess the degree of stenosis in each vein segment. The use of IVUS is critical to locate the narrow channel present between the contralateral stent and wall of the IVC, assist passage of the guidewire through this narrow channel, and ensure that the guidewire does not pass through the interstices of the stent (Fig 1) . Balloon angioplasty is seldom necessary. The initial guidewire is then exchanged for a stiff 0.35-inch Â 180-cm guidewire. Next, a 16-mm or 18-mm stent is positioned alongside the existing stent in a kissing iliac stents configuration. After the newly placed stent is deployed, both stents are simultaneously dilated with either 16-mm or 18-mm balloons (Fig 2) . Finally, a completion venogram and IVUS confirm fully expanded stents.
Results: This procedure was performed in 11 patients (6 males, 5 females), with three performed on the right iliac vein and eight on the left iliac vein. The mean time to development of contralateral occlusive symptoms was 626 days from the initial stenting. Average follow-up time from the second stenting was 167 days, with no postoperative complications. Eight patients reported significant symptomatic improvement in their newly treated limb at 30 days postoperatively, while 10 patients 
